FABRINET (FN) — Fundamental Analysis

Fabrinet is a contract manufacturer specializing in complex optical, networking, and photonics products — the kind of precision hardware that sits inside data centers, telecom networks, and medical devices. In plain terms: the company makes things other companies design, and it does so with remarkable consistency. Over the past decade, revenue has compounded at roughly 16% per year, growing from under $800 million to over $3.4 billion in fiscal 2025. Margins have been steady rather than spectacular — gross margins sit in the 11–12% range, typical for a high-quality contract manufacturer — but the business has become more profitable over time, with net margins now approaching 10%. The balance sheet is essentially debt-free, the current ratio is comfortably above 2.5x, and free cash flow generation is real. The most recent quarter (ending March 2026) shows the growth engine still running, with revenue on an annualized pace well above fiscal 2025 levels. Fabrinet is not a flashy growth story, but it is a financially disciplined, steadily expanding business operating in a sector with durable tailwinds from AI infrastructure and optical networking demand.

Snapshot & Big Picture

Fabrinet (NYSE: FN) operates as a premier outsourced manufacturer for companies that need extremely precise, low-volume, high-complexity products. Its customers include major names in optical communications and networking — markets that are benefiting directly from the surge in AI-driven data center buildouts. The company's fiscal year ends in late June, and its most recent full fiscal year (FY2025, ending June 27, 2025) reported revenue of $3.42 billion, EBITDA of $377.9 million, and net income margins of approximately 9.7%. The business carries essentially no debt — the debt-to-equity ratio was reported as null (effectively zero) for FY2025 — and maintains a current ratio of nearly 3.0x, reflecting a very conservative and liquid balance sheet.

Latest Quarter Snapshot

The most recent data available — and more current than the annual figures — comes from the 10-Q for the quarter ending March 27, 2026. This is Q3 of Fabrinet's fiscal year 2026. Revenue for the quarter came in at $1.214 billion, which on an annualized basis implies a run rate exceeding $4.8 billion — meaningfully above the full FY2025 result of $3.42 billion. That suggests the growth trajectory has continued to accelerate into fiscal 2026. Operating margin for the quarter was 9.9% and net margin was 10.3%, both at or near the high end of recent historical ranges. EBITDA for the quarter was $134.9 million. The current ratio dipped slightly to 2.55x, still healthy, while the debt-to-equity ratio was essentially negligible at 0.003x — the company has very minimal debt outstanding. Capital expenditures for the quarter were $45.3 million, or about 3.7% of revenue, which is elevated relative to recent annual averages and worth watching (discussed further below).

Profitability

Fabrinet's profitability story is one of steady, gradual improvement rather than dramatic expansion. Gross margins have hovered in a tight band — roughly 11.2% to 12.7% over the past decade — which is characteristic of the contract manufacturing model where pricing is largely cost-plus and there is limited pricing power. However, operating and net margins have improved meaningfully over the long run. Net margin has climbed from about 5.6% in FY2015 to approximately 9.7% in FY2025, reflecting operating leverage, better overhead absorption as revenue has scaled, and disciplined cost management. Operating margin has similarly trended upward, from around 6.1% in FY2015 to 9.5% in FY2025. The most recent quarter shows net margin of 10.3%, near the top of the historical range — a positive sign. There is no dramatic margin compression visible, and the direction of travel is constructive. For a contract manufacturer, margins in this territory — combined with the revenue scale Fabrinet has achieved — represent a genuinely strong financial profile.

Financial Health & Capital Expenditures

Fabrinet's balance sheet is exceptionally clean. The company has operated with effectively zero long-term debt for multiple years — debt-to-equity was reported as null (not applicable) in FY2025, reflecting the absence of meaningful debt obligations. In prior years the ratio was very low, peaking modestly around 0.07x. The current ratio has remained above 2.5x across all years in the dataset, and above 3.0x in most years, indicating ample short-term liquidity. This financial conservatism gives Fabrinet resilience in downturns and flexibility to invest opportunistically.

Capital expenditures are a key consideration for a precision manufacturer. The trend here is nuanced. CapEx as a percentage of revenue declined significantly from a peak of 6.6% in FY2015 down to a low of 1.6% in FY2024 — a period where the company generated substantial free cash flow without heavy reinvestment. However, CapEx jumped to 3.5% of revenue in FY2025 ($121.1 million) and is running at 3.7% in the most recent quarter ($45.3 million). This uptick likely reflects investment in capacity expansion to support growing demand, particularly from AI and optical networking customers. While capital intensity is rising from recent lows, it remains well within historical norms and does not suggest the business model is becoming structurally more capital-hungry — rather, it is scaling capacity in response to demand.

Growth

Revenue growth has been one of Fabrinet's defining characteristics over the past decade. The table below shows trailing compound annual growth rates (CAGR) over three, five, and ten fiscal years, computed directly from annual 10-K filings.

What stands out here is the remarkable consistency: three-, five-, and ten-year CAGRs all cluster tightly around 15–16%, suggesting this is not a lumpy or cyclical growth story but a business with durable, compounding demand. The slight step-down in the three-year figure (14.8%) relative to the longer windows could reflect a higher base from the post-pandemic surge, but given the acceleration visible in Q3 FY2026's run rate, there is no obvious sign of deceleration in the near term.

Source Filings

• Form 10-Q — Filed May 5, 2026 (Period ending March 27, 2026)
• Form 10-Q — Filed February 3, 2026 (Period ending December 26, 2025)